Allarity Therapeutics Inc (ALLR)

Currency in USD
1.020
0.000(0.00%)
Closed·
After Hours
1.000-0.020(-1.96%)
·
ALLR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ALLR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.9891.030
52 wk Range
0.6147.380
Key Statistics
Prev. Close
1.02
Open
1.02
Day's Range
0.989-1.03
52 wk Range
0.614-7.38
Volume
304.23K
Average Volume (3m)
578.08K
1-Year Change
-80.97%
Book Value / Share
1.1
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALLR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Allarity Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy

Allarity Therapeutics Inc Company Profile

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2 clinical trial in patients with advanced and recurrent ovarian cancer. The company also develops stenoparib- DRP, a companion diagnostic product used in select patients for stenoparib treatment. Allarity Therapeutics, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Compare ALLR to Peers and Sector

Metrics to compare
ALLR
Peers
Sector
Relationship
P/E Ratio
−0.6x−5.6x−0.5x
PEG Ratio
-0.020.00
Price/Book
0.8x3.7x2.6x
Price / LTM Sales
-239.3x3.2x
Upside (Analyst Target)
-151.9%40.5%
Fair Value Upside
Unlock7.8%4.4%Unlock

Earnings

Latest Release
May 09, 2025
EPS / Forecast
-0.25 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ALLR Income Statement

People Also Watch

2.25
BMGL
+0.45%
1.23
KLTO
-3.15%
1.1400
GNS
-4.20%
0.833
BKYI
+0.36%
7.220
COMP
+1.26%

FAQ

What Stock Exchange Does Allarity Therapeutics Trade On?

Allarity Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Allarity Therapeutics?

The stock symbol for Allarity Therapeutics is "ALLR."

What Is the Allarity Therapeutics Market Cap?

As of today, Allarity Therapeutics market cap is 15.38M.

What Is Allarity Therapeutics's Earnings Per Share (TTM)?

The Allarity Therapeutics EPS (TTM) is -5.47.

From a Technical Analysis Perspective, Is ALLR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Allarity Therapeutics Stock Split?

Allarity Therapeutics has split 4 times.

How Many Employees Does Allarity Therapeutics Have?

Allarity Therapeutics has 7 employees.

What is the current trading status of Allarity Therapeutics (ALLR)?

As of 25 Jul 2025, Allarity Therapeutics (ALLR) is trading at a price of 1.02, with a previous close of 1.02. The stock has fluctuated within a day range of 0.99 to 1.03, while its 52-week range spans from 0.61 to 7.38.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.